ArticleTranslational cancer research2022

Infliximab in the treatment of tislelizumab-induced steroid-refractory immune checkpoint inhibitor-related pneumonia: case report and literature review.

Zhujun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.